These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 29406782)

  • 1. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
    Maekawa R; Ogata H; Murase M; Harada N; Suzuki K; Joo E; Sankoda A; Iida A; Izumoto T; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Arima H; Hayashi Y; Seino Y
    Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E572-E583. PubMed ID: 29406782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
    Murata Y; Harada N; Yamane S; Iwasaki K; Ikeguchi E; Kanemaru Y; Harada T; Sankoda A; Shimazu-Kuwahara S; Joo E; Poudyal H; Inagaki N
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E53-E64. PubMed ID: 30990747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
    Nasteska D; Harada N; Suzuki K; Yamane S; Hamasaki A; Joo E; Iwasaki K; Shibue K; Harada T; Inagaki N
    Diabetes; 2014 Jul; 63(7):2332-43. PubMed ID: 24584548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
    Moffett RC; Vasu S; Flatt PR
    Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of GIP secretion alleviates age-related obesity and insulin resistance.
    Kanemaru Y; Harada N; Shimazu-Kuwahara S; Yamane S; Ikeguchi E; Murata Y; Kiyobayashi S; Hatoko T; Inagaki N
    J Endocrinol; 2020 Apr; 245(1):13-20. PubMed ID: 31977316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
    Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
    Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
    Hwang JS; Park JW; Nam MS; Cho H; Han IO
    Metabolism; 2015 Mar; 64(3):368-79. PubMed ID: 25516476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
    Yamane S; Harada N; Inagaki N
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):20-6. PubMed ID: 27186351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
    Irwin N; Hunter K; Flatt PR
    Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
    McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.
    Porter DW; Irwin N; Flatt PR; Hölscher C; Gault VA
    Eur J Pharmacol; 2011 Jan; 650(2-3):688-93. PubMed ID: 21050845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
    Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
    Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
    Irwin N; McClean PL; Hunter K; Flatt PR
    Diabetes Obes Metab; 2009 Jun; 11(6):603-10. PubMed ID: 19515180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.
    Boer GA; Hunt JE; Gabe MBN; Windeløv JA; Sparre-Ulrich AH; Hartmann B; Holst JJ; Rosenkilde MM
    Br J Pharmacol; 2022 Sep; 179(18):4486-4499. PubMed ID: 35710141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.
    Althage MC; Ford EL; Wang S; Tso P; Polonsky KS; Wice BM
    J Biol Chem; 2008 Jun; 283(26):18365-76. PubMed ID: 18420580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice.
    McShane LM; Irwin N; O'Flynn D; Franklin ZJ; Hewage CM; O'Harte FP
    J Endocrinol; 2016 Jun; 229(3):319-30. PubMed ID: 27098830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
    Pathak V; Gault VA; Flatt PR; Irwin N
    Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.